MAT
51
-3
L
55
-4
MLM
53
-5
NVDA
52
-3
MMM
52
2
WEC
45
2
EMR
57
-3
BRK.B
42
-3
PYPL
43
-4
ILMN
41
-3
KMI
59
2
PRGO
44
-2
DHR
56
-4
AMG
41
-3
PPG
61
-5
HRL
30
-5
CL
58
2
WBA
24
-3
EMN
70
-2
AME
57
-2
MAT
51
-3
L
55
-4
MLM
53
-5
NVDA
52
-3
MMM
52
2
WEC
45
2
EMR
57
-3
BRK.B
42
-3
PYPL
43
-4
ILMN
41
-3
KMI
59
2
PRGO
44
-2
DHR
56
-4
AMG
41
-3
PPG
61
-5
HRL
30
-5
CL
58
2
WBA
24
-3
EMN
70
-2
AME
57
-2
Financhill
Back

SPDR® Kensho Clean Power ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
40

CNRG
SPDR® Kensho Clean Power ETF

Last Price:
64.35
Seasonality Move:
6.37%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.15
Seasonality Move:
18.8%
Sell
40
SPDR® Kensho Clean Power ETF (CNRG) is a Sell

Is SPDR® Kensho Clean Power ETF a Buy, Sell or Hold?

  • The current SPDR® Kensho Clean Power ETF [CNRG] share price is $63.93. The Score for CNRG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CNRG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CNRG Stock Price Chart

What is SPDR® Kensho Clean Power ETF's stock price today?

  • The SPDR® Kensho Clean Power ETF share price today is $63.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNRG is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CNRG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 59.68 Buy
Chaikin Money Flow: 1474 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.76 - 63.14) Buy
Bollinger Bands (100): (59.95 - 65.51) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CNRG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.15 Buy
20-day SMA: 61.62 Buy
50-day SMA: 61.64 Buy
200-day SMA: 63.41 Buy
8-day EMA: 63.11 Buy
20-day EMA: 61.98 Buy
50-day EMA: 61.76 Buy
200-day EMA: 64.29 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

SPDR® Kensho Clean Power ETF Earnings Growth & CNRG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

SPDR® Kensho Clean Power ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):